ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease
Presenter: Julinda Mehilli
Up Next
Presenter: Philippe Selleslagh
More slides +
Presenter: Wilson Szeto
Presenter: Akihiro Koide